Cas:850444-36-9 (S)-(+)-[(S)-2-Diphenylphosphinoferrocenyl] (N,N-dimethylamino) (2-diphenylphosphinophenyl)methane manufacturer & supplier

Chemical Name:(S)-(+)-[(S)-2-Diphenylphosphinoferrocenyl] (N,N-dimethylamino) (2-diphenylphosphinophenyl)methane

CAS.NO:850444-36-9

Synonyms:MFCD04117709;taniaphos

Molecular Formula:C₄₃H₃₉FeNP₂

Molecular Weight:687.56900

HS Code:29319090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:30.42000

Exact Mass:687.19100

LogP:7.64600

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:NONH for all modes of transpor

Packing Group:

Contact us for information like MFCD04117709 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,taniaphos physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,MFCD04117709 Use and application,taniaphos technical grade,usp/ep/jp grade.

Related News: Delta moved the date up after the US State Department warned that people should not travel to China due to concerns about the spread of coronavirus, which was first discovered in Wuhan, Hubei province, in December. (S)-(+)-[(S)-2-Diphenylphosphinoferrocenyl] (N,N-dimethylamino) (2-diphenylphosphinophenyl)methane manufacturer Delta moved the date up after the US State Department warned that people should not travel to China due to concerns about the spread of coronavirus, which was first discovered in Wuhan, Hubei province, in December. (S)-(+)-[(S)-2-Diphenylphosphinoferrocenyl] (N,N-dimethylamino) (2-diphenylphosphinophenyl)methane supplier Complete the research and development of APIs and intermediates, design new patented process routes, and explore new crystal forms. (S)-(+)-[(S)-2-Diphenylphosphinoferrocenyl] (N,N-dimethylamino) (2-diphenylphosphinophenyl)methane vendor The oral form of rigosertib was developed to provide a potentially more convenient dosage form for use where the duration of treatment may extend to multiple years. (S)-(+)-[(S)-2-Diphenylphosphinoferrocenyl] (N,N-dimethylamino) (2-diphenylphosphinophenyl)methane factory The oral form of rigosertib was developed to provide a potentially more convenient dosage form for use where the duration of treatment may extend to multiple years.